NanoCarrier Co., Ltd

4571
End-of-day quote Tokyo - 07/19
284JPY
+0.35%
Prev.283.0000
Open283.0000
High287.0000
Low282.0000
Volume998 700
Financials
Sales 2020 560 M
EBIT 2020 -1 838 M
Net income 2020 -1 839 M
Debt 2020 -
Yield 2020 -
P/E ratio 2020 -7,34x
P/E ratio 2021 -10,2x
Capi. / Sales2020 28,6x
Capi. / Sales2021 17,3x
Capitalization 16 007 M
Company
NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar...
Sector :
Bio Therapeutic Drugs
Calendar :
2019-08-09 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
01/30SanBio's crash causes margin calls, drags down Japan's start-up market
RE
2018NANOCARRIER CO., LTD. : quaterly earnings release
2016NANOCARRIER CO., LTD. : half-yearly earnings release
2016NANOCARRIER CO., LTD. : quaterly earnings release
2016NANOCARRIER CO., LTD. : annual earnings release
2014NANOCARRIER CO., LTD. : SPLIT: 100 of 1
FA
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance305376391
Spread/Res.-6,9%-24%-27%
Spread/Supp.0,35%0,35%19%
Support283283239